213 related articles for article (PubMed ID: 27097222)
1. Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion.
Sengers BG; McGinty S; Nouri FZ; Argungu M; Hawkins E; Hadji A; Weber A; Taylor A; Sepp A
MAbs; 2016 Jul; 8(5):905-15. PubMed ID: 27097222
[TBL] [Abstract][Full Text] [Related]
2. The comparison of the ability of monoclonal antibodies directed to different proteins (human IgG, human myoglobin and HRP) and bispecific antibodies derived thereof to bind antigens immobilized on a surface of a solid phase.
Dmitriev DA; Massino YS; Segal OL; Smirnova MB; Kolyaskina GI; Pavlova EV; Osipov AP; Egorov AM; Dmitriev AD
Clin Chim Acta; 2001 Jul; 309(1):57-71. PubMed ID: 11408007
[TBL] [Abstract][Full Text] [Related]
3. Insights into the molecular basis of a bispecific antibody's target selectivity.
Mazor Y; Hansen A; Yang C; Chowdhury PS; Wang J; Stephens G; Wu H; Dall'Acqua WF
MAbs; 2015; 7(3):461-9. PubMed ID: 25730144
[TBL] [Abstract][Full Text] [Related]
4. Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29.
Duke-Cohan JS; Morimoto C; Schlossman SF
Transplantation; 1993 Nov; 56(5):1188-96. PubMed ID: 7504344
[TBL] [Abstract][Full Text] [Related]
5. A Modeling and Experimental Investigation of the Effects of Antigen Density, Binding Affinity, and Antigen Expression Ratio on Bispecific Antibody Binding to Cell Surface Targets.
Rhoden JJ; Dyas GL; Wroblewski VJ
J Biol Chem; 2016 May; 291(21):11337-47. PubMed ID: 27022022
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the binding of bispecific monoclonal antibodies with immobilized antigens (human IgG and horseradish peroxidase) using a resonant mirror biosensor.
Dmitriev DA; Massino YS; Segal OL; Smirnova MB; Pavlova EV; Gurevich KG; Gnedenko OV; Ivanov YD; Kolyaskina GI; Archakov AI; Osipov AP; Dmitriev AD; Egorov AM
J Immunol Methods; 2002 Mar; 261(1-2):103-18. PubMed ID: 11861069
[TBL] [Abstract][Full Text] [Related]
7. GingisKHAN™ protease cleavage allows a high-throughput antibody to Fab conversion enabling direct functional assessment during lead identification of human monoclonal and bispecific IgG1 antibodies.
Moelleken J; Endesfelder M; Gassner C; Lingke S; Tomaschek S; Tyshchuk O; Lorenz S; Reiff U; Mølhøj M
MAbs; 2017 Oct; 9(7):1076-1087. PubMed ID: 28805498
[TBL] [Abstract][Full Text] [Related]
8. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
Tustian AD; Endicott C; Adams B; Mattila J; Bak H
MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
[TBL] [Abstract][Full Text] [Related]
9. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody.
Israel BF; Pickles RJ; Segal DM; Gerard RD; Kenney SC
J Virol; 2001 Jun; 75(11):5215-21. PubMed ID: 11333903
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence.
Mazor Y; Sachsenmeier KF; Yang C; Hansen A; Filderman J; Mulgrew K; Wu H; Dall'Acqua WF
Sci Rep; 2017 Jan; 7():40098. PubMed ID: 28067257
[TBL] [Abstract][Full Text] [Related]
12. [The binding of bispecific monoclonal antibodies to the solid phase-adsorbed antigens].
Dmitriev DA; Massino IuS; Smirnova MB; Segal OL; Pavlova EB; Koliaskina GI; Osipov AP; Egorov AM; Dmitriev AD
Bioorg Khim; 2001; 27(4):265-74. PubMed ID: 11558260
[TBL] [Abstract][Full Text] [Related]
13. Optimizing properties of antireceptor antibodies using kinetic computational models and experiments.
Harms BD; Kearns JD; Su SV; Kohli N; Nielsen UB; Schoeberl B
Methods Enzymol; 2012; 502():67-87. PubMed ID: 22208982
[TBL] [Abstract][Full Text] [Related]
14. ELISA-based method for determining the affinity of bivalent antibodies of two specificities in a mixture.
Bobrovnik SA
Ukr Biokhim Zh (1999); 2000; 72(3):133-41. PubMed ID: 11200468
[TBL] [Abstract][Full Text] [Related]
15. Analysis of bispecific monoclonal antibody binding to immobilized antigens using an optical biosensor.
Dmitriev DA; Massino YS; Segal OL; Smirnova MB; Pavlova EV; Kolyaskina GI; Gurevich KG; Gnedenko OV; Ivanov YD; Archakov AI; Osipov AP; Dmitriev AD; Egorov AM
Biochemistry (Mosc); 2002 Dec; 67(12):1356-65. PubMed ID: 12600264
[TBL] [Abstract][Full Text] [Related]
16. Stochastic Reaction-Diffusion Model of the Binding of Monoclonal Antibodies to CD4 Receptors on the Surface of T Cells.
Wang L; DeRose PC; Inwood SL; Gaigalas AK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846978
[TBL] [Abstract][Full Text] [Related]
17. Improving target cell specificity using a novel monovalent bispecific IgG design.
Mazor Y; Oganesyan V; Yang C; Hansen A; Wang J; Liu H; Sachsenmeier K; Carlson M; Gadre DV; Borrok MJ; Yu XQ; Dall'Acqua W; Wu H; Chowdhury PS
MAbs; 2015; 7(2):377-89. PubMed ID: 25621507
[TBL] [Abstract][Full Text] [Related]
18. A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DR.
Zeng J; Liu R; Wang J; Fang Y
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1899-907. PubMed ID: 25773122
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale spatial dependence of avidity in an IgG1 antibody.
Jendroszek A; Kjaergaard M
Sci Rep; 2021 Jun; 11(1):12663. PubMed ID: 34135438
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
Russoniello C; Somasundaram C; Schlom J; Deo YM; Keler T
Clin Cancer Res; 1998 Sep; 4(9):2237-43. PubMed ID: 9748144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
